Abstract Background Semantic variant primary progressive aphasia (svPPA) is a subtype of primary progressive aphasia characterized by two-way anomia and disturbance in word comprehension, with focal atrophy in the left temporal lobe. [18F]THK-5351 was originally developed to trace tau protein. However, it has recently been suggested that [18F]THK-5351 binds to monoamine oxidase B in astrocytes, which reflects gliosis. Herein, the authors present two cases involving patients with early-stage svPPA who underwent [18F]THK-5351 positron emission tomography (PET) imaging, and examined whether [18F]THK-5351 PET imaging is more sensitive to neurodegenerative lesions than conventional imaging modalities such as magnetic resonance imaging (MRI) and ...
Background: A subset of patients with the nonfluent variant of primary progressive aphasia (PPA) exh...
Figure S1. THK-5351 PET images in a healthy control (81-year-old female), Alzheimerâs disease (80-...
Importance:The ability to predict the pathology underlying different neurodegenerative syndromes is ...
Purpose: To assess the binding of the PET tracer [18F]THK5351 in patients with different primary pro...
Purpose To assess the binding of the PET tracer [18F]THK5351 in patients with different primary prog...
We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semant...
Background: Primary progressive aphasia (PPA) is a progressive language disorder associated with atr...
PURPOSE: In vivo tau-PET tracer retention in the anterior temporal lobe of patients with semantic va...
Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) pa...
International audienceWithin primary progressive aphasia the logopenic variant remains less understo...
Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of ...
Abstract Recent positron emission tomography (PET) studies have demonstrated the accumulation of tau...
Despite epidemiological and genetic data linking semantic dementia to inflammation, the topography o...
INTRODUCTION: Semantic dementia, including the semantic variant of primary progressive aphasia (svPP...
Background and Objective: Primary progressive aphasia (PPA) is a clinical syndrome due to different ...
Background: A subset of patients with the nonfluent variant of primary progressive aphasia (PPA) exh...
Figure S1. THK-5351 PET images in a healthy control (81-year-old female), Alzheimerâs disease (80-...
Importance:The ability to predict the pathology underlying different neurodegenerative syndromes is ...
Purpose: To assess the binding of the PET tracer [18F]THK5351 in patients with different primary pro...
Purpose To assess the binding of the PET tracer [18F]THK5351 in patients with different primary prog...
We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semant...
Background: Primary progressive aphasia (PPA) is a progressive language disorder associated with atr...
PURPOSE: In vivo tau-PET tracer retention in the anterior temporal lobe of patients with semantic va...
Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) pa...
International audienceWithin primary progressive aphasia the logopenic variant remains less understo...
Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of ...
Abstract Recent positron emission tomography (PET) studies have demonstrated the accumulation of tau...
Despite epidemiological and genetic data linking semantic dementia to inflammation, the topography o...
INTRODUCTION: Semantic dementia, including the semantic variant of primary progressive aphasia (svPP...
Background and Objective: Primary progressive aphasia (PPA) is a clinical syndrome due to different ...
Background: A subset of patients with the nonfluent variant of primary progressive aphasia (PPA) exh...
Figure S1. THK-5351 PET images in a healthy control (81-year-old female), Alzheimerâs disease (80-...
Importance:The ability to predict the pathology underlying different neurodegenerative syndromes is ...